| scholarly article | Q13442814 |
| P50 | author | Shile Huang | Q37840632 |
| P2093 | author name string | Min Guo | |
| Lei Liu | |||
| Qian Zhou | |||
| Hai Zhang | |||
| Long Chen | |||
| Chong Xu | |||
| Qian Ren | |||
| Chunxiao Liu | |||
| Sujuan Chen | |||
| Yangjing Ye | |||
| Yijiao Xu | |||
| P2860 | cites work | Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila | Q36891456 |
| Role of mTOR in physiology and pathology of the nervous system | Q36959417 | ||
| mTOR and the control of whole body metabolism | Q37406462 | ||
| The hypoxia-inducible factor 1/NOR-1 axis regulates the survival response of endothelial cells to hypoxia | Q37410754 | ||
| Pathological roles of MAPK signaling pathways in human diseases | Q37676393 | ||
| mTOR in aging, metabolism, and cancer | Q38073906 | ||
| Dysregulated mTOR-dependent signaling in neurodegeneration or carcinogenesis: implication for Alzheimer's disease and brain tumors. | Q38129230 | ||
| The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease. | Q39244135 | ||
| Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival | Q39446473 | ||
| Hydrogen peroxide inhibits mTOR signaling by activation of AMPKalpha leading to apoptosis of neuronal cells | Q39741931 | ||
| AMP-activated protein kinase is activated in Parkinson's disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Q39776724 | ||
| Involvement of ERK1/2 signaling pathway in DJ-1-induced neuroprotection against oxidative stress | Q39860196 | ||
| Reactive oxygen species production and MAPK activation are implicated in tetrahydrobiopterin-induced SH-SY5Y cell death | Q39915973 | ||
| MAPK and mTOR pathways are involved in cadmium-induced neuronal apoptosis | Q40049797 | ||
| Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways | Q40277182 | ||
| Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons | Q40583837 | ||
| Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease | Q40887263 | ||
| Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease | Q44047703 | ||
| Etiology and pathogenesis of Parkinson disease. | Q45952835 | ||
| Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2 | Q21145847 | ||
| Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 | ||
| Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton | Q24299873 | ||
| Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive | Q24306328 | ||
| mTOR signaling in growth control and disease | Q24634174 | ||
| Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin | Q27015640 | ||
| Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke | Q28240112 | ||
| Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases | Q28269333 | ||
| RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation | Q28568796 | ||
| Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway | Q28569460 | ||
| Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death | Q28577801 | ||
| Cadmium activates the mitogen-activated protein kinase (MAPK) pathway via induction of reactive oxygen species and inhibition of protein phosphatases 2A and 5 | Q28583048 | ||
| Parkinson's disease: mechanisms and models | Q29547424 | ||
| Regulation of neuronal survival by the serine-threonine protein kinase Akt | Q29614185 | ||
| Molecular mechanisms of mTOR-mediated translational control | Q29615529 | ||
| Oxidative stress in Parkinson's disease | Q29618017 | ||
| AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy | Q29618101 | ||
| Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins | Q30438876 | ||
| A highly reproducible rotenone model of Parkinson's disease | Q30490799 | ||
| Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease | Q33951094 | ||
| Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. | Q34308036 | ||
| Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. | Q34349122 | ||
| Levodopa and the progression of Parkinson's disease | Q34553278 | ||
| RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation. | Q34569422 | ||
| AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathies | Q34696305 | ||
| Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease | Q35942562 | ||
| Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1 | Q36158367 | ||
| Expanding insights of mitochondrial dysfunction in Parkinson's disease. | Q36404133 | ||
| Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites | Q36604979 | ||
| The growing role of mTOR in neuronal development and plasticity. | Q36739424 | ||
| Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease | Q36820873 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| cell death | Q2383867 | ||
| P1104 | number of pages | 10 | |
| P304 | page(s) | 1680-1689 | |
| P577 | publication date | 2014-04-12 | |
| P1433 | published in | Cellular Signalling | Q1524097 |
| P1476 | title | Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease | |
| P478 | volume | 26 |
| Q88252675 | (-)-Guaiol regulates autophagic cell death depending on mTOR signaling in NSCLC |
| Q37210035 | 1-(2-Hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione Induces G1 Cell Cycle Arrest and Autophagy in HeLa Cervical Cancer Cells |
| Q101410046 | A transition to degeneration triggered by oxidative stress in degenerative disorders |
| Q58586822 | AMP Kinase Activation is Selectively Disrupted in the Ventral Midbrain of Mice Deficient in Parkin or PINK1 Expression |
| Q47303865 | AMP-activated protein kinase activation in mediating phenylalanine-induced neurotoxicity in experimental models of phenylketonuria |
| Q38998405 | AMPK in Neurodegenerative Diseases |
| Q64276536 | Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson's Disease |
| Q47099058 | Cordyceps militaris improves the survival of Dahl salt-sensitive hypertensive rats possibly via influences of mitochondria and autophagy functions |
| Q36946559 | Crosstalk between Ca2+ signaling and mitochondrial H2O2 is required for rotenone inhibition of mTOR signaling pathway leading to neuronal apoptosis. |
| Q37689001 | Curcumin targets the TFEB-lysosome pathway for induction of autophagy. |
| Q91583464 | Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences |
| Q37745507 | Endogenous AMPK acts as a detrimental factor in fulminant hepatitis via potentiating JNK-dependent hepatocyte apoptosis |
| Q51691934 | Glucose Metabolism and AMPK Signaling Regulate Dopaminergic Cell Death Induced by Gene (α-Synuclein)-Environment (Paraquat) Interactions. |
| Q61453559 | Hepatoprotective Effect of Baicalein Against Acetaminophen-Induced Acute Liver Injury in Mice |
| Q35082315 | Host response during Yersinia pestis infection of human bronchial epithelial cells involves negative regulation of autophagy and suggests a modulation of survival-related and cellular growth pathways. |
| Q90237363 | Maduramicin induces cardiac muscle cell death by the ROS-dependent PTEN/Akt-Erk1/2 signaling pathway |
| Q46309597 | Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders |
| Q92549553 | Mechanistic target of rapamycin signaling in mouse models of accelerated aging |
| Q39199926 | Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism. |
| Q38539848 | Mitochondrial dysfunction and Parkinson disease: a Parkin-AMPK alliance in neuroprotection |
| Q47988278 | Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity. |
| Q61801081 | Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson's disease |
| Q48290344 | Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways. |
| Q43679571 | Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update |
| Q59808772 | Novel Factors of Viral Origin Inhibit TOR Pathway Gene Expression |
| Q26752769 | Nutraceuticals in Parkinson's Disease |
| Q64275885 | Polysaccharides Prevent Palmitic Acid-Evoked Apoptosis and Autophagy in Intestinal Porcine Epithelial Cell Line via Restoration of Mitochondrial Function and Regulation of MAPK and AMPK/Akt/mTOR Signaling Pathway |
| Q64082784 | Prioritizing Parkinson's disease genes using population-scale transcriptomic data |
| Q58702868 | Punicalagin Exerts Beneficial Functions in 6-Hydroxydopamine-Treated SH-SY5Y Cells by Attenuating Mitochondrial Dysfunction and Inflammatory Responses |
| Q36356365 | Rapamycin inhibits Erk1/2-mediated neuronal apoptosis caused by cadmium. |
| Q92715084 | Revealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain |
| Q34760248 | Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis |
| Q27314642 | Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2, and autophagy pathways |
| Q52609727 | Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease. |
| Q38607849 | Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders |
| Q92257585 | The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury |
| Q26768527 | The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action |
| Q38765856 | Therapeutic potential of autophagy-enhancing agents in Parkinson's disease. |
| Q38855225 | mTOR Signaling in Parkinson's Disease |
| Q90145983 | mTOR activation due to APPL1 deficiency exacerbates hyperalgesia via Rab5/Akt and AMPK signaling pathway in streptozocin-induced diabetic rats |
| Q92993163 | mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival |
| Q58795101 | mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases |
| Q54114653 | δ-Opioid Receptor Activation Attenuates Hypoxia/MPP+-Induced Downregulation of PINK1: a Novel Mechanism of Neuroprotection Against Parkinsonian Injury. |
Search more.